[1]
“EVALUATE THE EFFICACY OF LONG-COURSE NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE II–III LOW RECTAL CANCER TREATED AT 108 MILITARY CENTRAL HOSPITAL”., YHCĐ, vol. 67, no. CĐ7-Trường ĐH Y Dược Hải Phòng, July 2026, doi: 10.52163/yhc.v67iCD7.5614.